Jazz Pharmaceuticals PLC
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 6.5% | 8.5% | 6.7% | 7.3% | 7.6% | 5.8% | 7.6% | 6.9% | 5.7% | 5.5% | 6.6% | 5.2% | 5.8% | 6.1% | 5.4% | 5.0% | 7.0% | 7.5% | 6.6% | 15.9% | 17.3% | 15.2% | 14.2% | 13.3% | 14.2% | 17.2% | 14.4% | 10.2% | 10.5% | 25.6% | 10.6% | 10.7% | 10.6% | 11.8% | 11.7% | 11.1% | 22.9% | 2.1% | 28.7% | 9.6% | 15.3% | |
| 93.5% | 91.5% | 93.3% | 92.7% | 92.4% | 94.2% | 92.4% | 93.1% | 94.3% | 94.5% | 93.4% | 94.8% | 94.2% | 93.9% | 94.6% | 95.0% | 93.0% | 92.5% | 93.4% | 84.1% | 82.7% | 84.8% | 85.8% | 86.7% | 85.8% | 82.8% | 85.6% | 89.8% | 89.5% | 74.4% | 89.4% | 89.3% | 89.4% | 88.2% | 88.3% | 88.9% | 77.1% | 97.9% | 71.3% | 90.4% | 84.7% | |
| 12.8% | 11.1% | 11.9% | 10.2% | 11.5% | 15.1% | 14.1% | 11.2% | 10.9% | 11.9% | 11.8% | 11.7% | 14.9% | 16.7% | 16.1% | 14.0% | 13.1% | 13.8% | 12.6% | 17.7% | 16.8% | 17.3% | 16.0% | 14.9% | 15.8% | 17.8% | 21.2% | 21.9% | 24.1% | 21.4% | 24.7% | 21.6% | 19.0% | 22.1% | 20.1% | 18.2% | 21.4% | 14.3% | 12.5% | 17.2% | 16.4% | |
| 33.2% | 31.7% | 38.4% | 33.5% | 30.2% | 32.8% | 46.6% | 31.7% | 33.2% | 34.0% | 33.0% | 33.0% | 33.2% | 36.8% | 39.0% | 34.0% | 34.5% | 37.1% | 42.9% | 57.1% | 43.4% | 44.4% | 38.0% | 39.3% | 38.1% | 39.4% | 33.4% | 35.6% | 31.7% | 39.1% | 39.0% | 33.1% | 30.9% | 33.9% | 57.2% | 34.3% | 47.1% | 33.9% | 33.0% | 32.2% | 36.5% | |
| 57.1% | 49.8% | 57.1% | 50.9% | 71.4% | 61.9% | 72.6% | 62.5% | 54.1% | 55.6% | 67.1% | 56.6% | 69.4% | 83.4% | 130.1% | 59.8% | 60.3% | 66.4% | 66.7% | 93.4% | 79.3% | 79.3% | 75.1% | 77.5% | 83.2% | 71.3% | 71.5% | 73.3% | 71.8% | 54.4% | 82.1% | 69.8% | 64.8% | 70.6% | 94.6% | 154.5% | 72.0% | 22.0% | 51.3% | 69.8% | 53.6% | |
| 36.4% | 41.7% | 36.2% | 41.8% | 21.0% | 32.4% | 19.7% | 30.6% | 40.2% | 38.8% | 26.3% | 38.2% | 24.8% | 10.5% | -35.5% | 35.2% | 32.7% | 26.1% | 26.7% | -9.3% | 3.4% | 5.5% | 10.8% | 9.2% | 2.6% | 11.5% | 14.1% | 16.5% | 17.7% | 20.0% | 7.3% | 19.5% | 24.7% | 17.5% | -6.2% | -65.6% | 5.1% | 75.9% | 20.0% | 20.5% | 31.1% | |
| 4.9% | 4.8% | 5.0% | 4.6% | 4.7% | 4.9% | 4.6% | 3.9% | 4.0% | 3.8% | 3.5% | 3.4% | 3.3% | 3.1% | 3.5% | 4.7% | 4.6% | 4.1% | 4.5% | 9.2% | 11.1% | 9.9% | 8.7% | 6.8% | 8.5% | 7.6% | 8.3% | 7.7% | 7.4% | 8.9% | 7.3% | 6.1% | 5.6% | 4.7% | 6.0% | 4.5% | 4.3% | 3.8% | 5.9% | 3.1% | 4.2% | |
| 31.1% | 38.1% | 30.8% | 35.8% | 15.7% | 27.2% | 14.7% | 25.7% | 35.9% | 34.5% | 22.5% | 34.3% | 21.0% | 6.8% | -39.1% | 30.1% | 27.9% | 21.7% | 23.0% | -17.9% | -8.5% | -5.3% | 0.3% | 2.0% | -6.7% | -35.0% | 6.1% | 8.4% | 10.2% | 6.1% | -0.3% | 13.5% | 19.0% | 12.2% | -12.3% | -70.3% | 0.8% | 17.4% | 28.0% | 17.5% | 15.8% | |
| 7.8% | 8.7% | 7.8% | 9.0% | 0.3% | -26.0% | 4.3% | 7.3% | 4.1% | 1.1% | 5.7% | -14.7% | 2.0% | -5.9% | -9.6% | 9.7% | 3.2% | 1.6% | 3.0% | 30.4% | -2.2% | -1.4% | 0.1% | -1.7% | -4.6% | -10.3% | -1.7% | -2.5% | -4.9% | -3.3% | 1.3% | -3.0% | -1.4% | -5.3% | -2.0% | -1.6% | -21.5% | 0.4% | 0.6% | 1.5% | -4.6% | |
| 23.3% | 29.4% | 23.0% | 26.8% | 15.4% | 53.2% | 10.3% | 18.4% | 31.8% | 33.5% | 16.8% | 49.0% | 19.0% | 12.7% | -29.5% | 20.4% | 24.7% | 20.0% | 20.1% | -48.3% | -6.3% | -3.9% | 0.2% | 3.7% | -2.1% | -24.7% | 7.8% | 10.9% | 15.1% | 9.3% | -1.6% | 16.5% | 20.4% | 17.6% | -10.3% | -68.7% | 22.3% | 17.0% | 27.4% | 16.0% | 20.4% | |
| 51.1% | 52.3% | 43.9% | 49.8% | 51.4% | 47.2% | 32.5% | 50.9% | 51.1% | 61.6% | 49.2% | 50.8% | 46.8% | 41.1% | 40.4% | 47.8% | 46.2% | 42.2% | 38.7% | 10.9% | 22.7% | 57.7% | 41.9% | 34.0% | 31.6% | 25.6% | 38.6% | 32.7% | 34.3% | 35.7% | 29.8% | 35.5% | 40.2% | 36.5% | 15.5% | -49.2% | 20.9% | 36.1% | 50.9% | 35.4% | 35.6% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.